What You Should Know:
- Ambiq, a leader in low-power semiconductors, and Smartaly, an electronics design firm, have partnered to create an artificial intelligence (AI) powered handheld ECG monitor.
- The AI-powered ECG monitor device boasts not only exceptional battery life but also the power of AI for real-time health insights.
Week-long Monitoring on a Single Charge
Smartaly's ECG monitor leverages Ambiq's Apollo3 SoC, a third-generation system on a chip (SoC) specifically designed
Read More
ecg
AccurKardia Brings ECG Software to Lucem Health’s AI Platform
What You Should Know:
- AccurKardia, an ECG-led diagnostics software company, has announced a multi-year agreement with Lucem Health, a leading provider of clinical AI solutions.
- The partnership will allow AccurKardia to integrate its FDA-cleared ECG interpretation software platform, AccurECG, into Lucem Health's Reveal family of solutions, which identify patients who may be at higher risk of severe or chronic diseases.
Automated ECG Interpretation Cloud-Based Software
Read More
iRhythm Launches Wearable ECG Heart Monitor
What You Should Know:
iRhythm Technologies, Inc. today announced the U.S. launch of its next-generation Zio® monitor and enhanced Zio® long-term continuous monitoring (LTCM) service.Zio monitor is iRhythm’s smallest, lightest and thinnest cardiac monitor, enhancing the cardiac monitoring experience for patients and healthcare providers together with new service enhancements. The new Zio monitor is a prescription-only ECG monitor, which is an integral part of the Zio LTCM service.
Read More
FDA Clears Samsung’s Irregular Heart Rhythm Notification
What You Should Know:
Today, Samsung announced today its Irregular Heart Rhythm Notification feature of the Samsung Health Monitor App has been cleared by the FDA. With this new feature, Galaxy Watch users can be alerted when heart rhythms suggestive of atrial fibrillation (AFib) – a type of arrhythmia – are detected.The Irregular Heart Rhythm Notification works with the app’s existing on-demand Electrocardiogram function to proactively monitor heart rhythms suggestive of AFib, and
Read More
Risky Business of Health Trackers: What Digital Health Leaders Need to Know
Gone are the days when healthcare information was only available to us at the doctor’s office or through the office's online portals, and that’s in part due to the rapidly growing popularity of wearable technology devices. It’s estimated that 1 in 5 adults in the U.S. use a fitness or health tracker to monitor things such as heart rate, blood pressure, sleep cycle, and stress. But this information is being used beyond just monitoring specific conditions. Take me, for example; I personally use my
Read More
KLAS Names Chartis, Nordic, Tegria Top Performers for IT Advisory Services
What You Should Know:
- In the IT advisory space, many firms perform well, but the breadth of their expertise varies—some firms offer many services, while others focus on a specific area. KLAS's latest report examines the breadth of firms’ validated services as well as client satisfaction and performance consistency.
- To provide better transparency into IT advisory services, KLAS has broken them into the following four segments: IT planning and assessment, revenue cycle optimization,
Read More
The Quickening Pulse of the Ambulatory Diagnostic Cardiology Market
The Global Ambulatory Diagnostic Cardiology Market is evolving at a rapid pace, driven by technological developments, and shifting models of healthcare service delivery and funding. The overall market will grow from $2.5 billion in 2021, to $3.3 billion by 2026, with Long-Term ECG and, to a lesser extent, Mobile Cardiac Telemetry (MCT), being the principal engines of growth. Unsurprisingly, these two markets are garnering serious attention from large incumbent vendors in the more established
Read More
Anumana & Pfizer Partner on Amyloidosis AI-ECG Algorithm Development
What You Should Know:
- Anumana, an AI-driven health technology company and portfolio company of nference, today announced a multi-year agreement with Pfizer for Anumana to develop an investigational artificial intelligence electrocardiogram algorithm (AI-ECG) designed to enable the early identification of patients who may be at risk of cardiac amyloidosis.
- Anumana will conduct a clinical validation trial and pursue De Novo classification for the algorithm as a
Read More
Research Shows Power of Anumana AI-ECG Algorithms to Detect Heart Conditions
What You Should Know:
- The research is mounting to show that Anumana’s AI-ECG algorithms could dramatically improve screening for cardiovascular disease (CVD), providing early warnings of disease from just a standard electrocardiogram (ECG). Yesterday, a study was published in Nature Medicine that shows an Anumana AI algorithm applied to Apple Watch ECG recordings successfully identified a weak heart pump in patients.
- This follows other recent research findings, published in The
Read More
HeartSciences & Rutgers Partner to Develop AI-based ECG Algorithms
What You Should Know:
- Heart Test Laboratories, a medical technology company focused on saving lives by making an ECG a far more valuable screening tool through the use of Artificial Intelligence (AI), announced that it has entered into a multi-year collaboration agreement with Rutgers University (Rutgers).
- HeartSciences and Rutgers will collaborate to develop AI-based ECG algorithms, which are expected to accelerate HeartSciences’ product development pipeline and further expand the
Read More
